Filing Details
- Accession Number:
- 0001553878-13-000004
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-26 18:53:00
- Reporting Period:
- 2013-03-25
- Filing Date:
- 2013-03-26
- Accepted Time:
- 2013-03-26 18:53:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1178670 | Alnylam Pharmaceuticals Inc. | ALNY | Pharmaceutical Preparations (2834) | 770602661 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1192603 | P Kevin Starr | C/O Alnylam Pharmaceuticals 300 Third Street Cambridge MA 02142 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-03-25 | 26,631 | $0.95 | 26,631 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-03-25 | 26,631 | $23.56 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-03-26 | 26,000 | $0.95 | 26,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-03-26 | 26,000 | $23.41 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-03-25 | 26,631 | $0.00 | 26,631 | $0.95 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-03-26 | 26,000 | $0.00 | 26,000 | $0.95 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 26,000 | 2013-09-24 | No | 4 | M | Direct | |
| 0 | 2013-09-24 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2012.
- Sale prices ranged from $23.28 to $23.88.
- Sale prices ranged from $23.13 to $23.82.
- The stock option vested as to 25% of the shares on the first year anniversary of the grant date and ratably with respect to the remaining shares on the last day of each month for the three years thereafter.
Billionaire Hedge Funds
